vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and WESBANCO INC (WSBC). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $257.2M, roughly 1.9× WESBANCO INC). WESBANCO INC runs the higher net margin — 34.5% vs 6.8%, a 27.6% gap on every dollar of revenue. Over the past eight quarters, WESBANCO INC's revenue compounded faster (31.9% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
WesBanco, Inc., is a bank holding company headquartered in Wheeling, West Virginia, United States. It has over 200 branches in West Virginia, Ohio, Western Pennsylvania, Kentucky, Maryland, and Southern Indiana.
MD vs WSBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $257.2M |
| Net Profit | $33.7M | $88.6M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | 34.5% |
| Revenue YoY | -1.7% | — |
| Net Profit YoY | 10.5% | 54.4% |
| EPS (diluted) | $0.40 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $257.2M | ||
| Q4 25 | $493.8M | $265.6M | ||
| Q3 25 | $492.9M | $261.6M | ||
| Q2 25 | $468.8M | $260.7M | ||
| Q1 25 | $458.4M | $193.2M | ||
| Q4 24 | $502.4M | $162.9M | ||
| Q3 24 | $511.2M | $150.8M | ||
| Q2 24 | $504.3M | $147.9M |
| Q1 26 | — | $88.6M | ||
| Q4 25 | $33.7M | $91.1M | ||
| Q3 25 | $71.7M | $83.6M | ||
| Q2 25 | $39.3M | $57.4M | ||
| Q1 25 | $20.7M | $-9.0M | ||
| Q4 24 | $30.5M | $49.6M | ||
| Q3 24 | $19.4M | $37.3M | ||
| Q2 24 | $-153.0M | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | 9.9% | 43.2% | ||
| Q3 25 | 13.8% | 39.5% | ||
| Q2 25 | 12.8% | 27.2% | ||
| Q1 25 | 7.0% | -5.0% | ||
| Q4 24 | 7.8% | 38.0% | ||
| Q3 24 | 6.6% | 29.7% | ||
| Q2 24 | -31.3% | 23.7% |
| Q1 26 | — | 34.5% | ||
| Q4 25 | 6.8% | 34.3% | ||
| Q3 25 | 14.5% | 31.9% | ||
| Q2 25 | 8.4% | 22.0% | ||
| Q1 25 | 4.5% | -4.7% | ||
| Q4 24 | 6.1% | 30.5% | ||
| Q3 24 | 3.8% | 24.7% | ||
| Q2 24 | -30.3% | 19.5% |
| Q1 26 | — | $0.88 | ||
| Q4 25 | $0.40 | $0.97 | ||
| Q3 25 | $0.84 | $0.84 | ||
| Q2 25 | $0.46 | $0.57 | ||
| Q1 25 | $0.24 | $-0.15 | ||
| Q4 24 | $0.37 | $0.72 | ||
| Q3 24 | $0.23 | $0.54 | ||
| Q2 24 | $-1.84 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $4.1B |
| Total Assets | $2.2B | $27.5B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $375.2M | $956.1M | ||
| Q3 25 | $340.1M | $1.0B | ||
| Q2 25 | $224.7M | $1.2B | ||
| Q1 25 | $99.0M | $1.1B | ||
| Q4 24 | $229.9M | $568.1M | ||
| Q3 24 | $103.8M | $620.9M | ||
| Q2 24 | $19.4M | $486.8M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $4.1B | ||
| Q4 25 | $865.9M | $4.0B | ||
| Q3 25 | $890.7M | $4.1B | ||
| Q2 25 | $833.8M | $3.8B | ||
| Q1 25 | $789.2M | $3.8B | ||
| Q4 24 | $764.9M | $2.8B | ||
| Q3 24 | $732.5M | $2.8B | ||
| Q2 24 | $706.5M | $2.5B |
| Q1 26 | — | $27.5B | ||
| Q4 25 | $2.2B | $27.7B | ||
| Q3 25 | $2.2B | $27.5B | ||
| Q2 25 | $2.1B | $27.6B | ||
| Q1 25 | $2.0B | $27.4B | ||
| Q4 24 | $2.2B | $18.7B | ||
| Q3 24 | $2.1B | $18.5B | ||
| Q2 24 | $2.0B | $18.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $290.4M | ||
| Q3 25 | $137.3M | $116.9M | ||
| Q2 25 | $137.2M | $105.0M | ||
| Q1 25 | $-117.5M | $-26.4M | ||
| Q4 24 | $133.0M | $211.0M | ||
| Q3 24 | $91.8M | $60.7M | ||
| Q2 24 | $107.0M | $18.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $280.0M | ||
| Q3 25 | — | $114.9M | ||
| Q2 25 | — | $98.3M | ||
| Q1 25 | — | $-30.7M | ||
| Q4 24 | — | $200.7M | ||
| Q3 24 | — | $56.9M | ||
| Q2 24 | — | $17.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 105.4% | ||
| Q3 25 | — | 43.9% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | -15.9% | ||
| Q4 24 | — | 123.2% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | — | 11.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.9% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 3.19× | ||
| Q3 25 | 1.91× | 1.40× | ||
| Q2 25 | 3.49× | 1.83× | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 4.25× | ||
| Q3 24 | 4.72× | 1.63× | ||
| Q2 24 | — | 0.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WSBC
| Net Interest Income | $215.4M | 84% |
| Noninterest Income | $41.8M | 16% |
